Lynwood Capital Management »

Eli Lilly & Co. shares owned by Lynwood Capital Management

Quarter-by-quarter ownership of Eli Lilly & Co. (LLY) shares owned by Lynwood Capital Management from 13F filings

Historical chart of Lynwood Capital Management investment in Eli Lilly & Co.

Tip: Access up to 7 years of quarterly data

All positions including Eli Lilly & Co. held by Lynwood Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eli Lilly & Co. by Lynwood Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $78k 100 777.96

More positions owned by Lynwood Capital Management

Briacell Therapeutics Corp (BCTX)
Americas Gold And Silver Cor (USAS)
Vaneck Etf Trust Gold Miners Etf (GDX)
Altimmune Com New (ALT)
Immix Biopharma (IMMX)
Advanced Micro Devices (AMD)
Teck Resources CL B (TECK)
Petroleo Brasileiro Sa Petro Sponsored Adr (PBR)
Spire Global Com Cl A New (SPIR)
Sociedad Quimica Y Minera De Spon Adr Ser B (SQM)
Vermilion Energy (VET)
Lightspeed Commerce Sub Vtg Shs (LSPD)
Diamond Offshore Drilli (DO)
Mag Silver Corp (MAG)
Transocean Registered Shs (RIG)

View all positions for Lynwood Capital Management

Top funds holding Eli Lilly & Co.

Lilly Endowment
Vanguard Group
BlackRock
BlackRock
Pnc Financial Services
State Street Corporation
T. Rowe Price Associates
Capital World Investors
Jpmorgan Chase & Co
PRIMECAP Management Company
Geode Capital Management
Morgan Stanley
State Farm Mutual Automobile Insurance Company
International Assets Investment Management
Bank of America Corporation

View all funds holding Eli Lilly & Co.